Hans-Georg Krauesslich

Title: Innovations of Hans-Georg Krauesslich

Introduction

Hans-Georg Krauesslich is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of virology, particularly in the development of methods to block HIV entry into cells. His innovative approach has the potential to impact vaccine development and therapeutic strategies against viral infections.

Latest Patents

Krauesslich holds a patent for a method aimed at blocking HIV entry into dendritic cells. The patent, titled "Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose binding interactions with gangliosides," describes techniques to prevent viral entry by inhibiting the coupling of sialyllactose molecules in the viral membrane to the CD169/sialoadhesin receptor. This invention also includes vaccine compositions that utilize dendritic cells loaded with specific antigens, combined with compositions that prevent viral entry.

Career Highlights

Throughout his career, Krauesslich has worked with various organizations, including Laboratorios del Dr. Esteve S.A. and Fundació Privada Institut de Recerca de la Sida—Caixa. His work has focused on advancing the understanding of viral mechanisms and developing innovative solutions to combat viral infections.

Collaborations

Krauesslich has collaborated with notable colleagues such as Nuria Izquierdo Useros and Maier Lorizate. These collaborations have contributed to the advancement of research in the field of virology and the development of therapeutic strategies.

Conclusion

Hans-Georg Krauesslich's contributions to the field of virology through his innovative patent and collaborations highlight his commitment to advancing medical science. His work has the potential to lead to significant breakthroughs in the prevention and treatment of viral infections.